Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative)

Hepatology

Volumn 23, Issue 3, 1996, Pages 465-470

  Tameda, Yukihiko ^a   Hamada, Minoru ^a   Takase, Koujirou ^a   Nakano, Takeshi ^a   Kosaka, Yoshitane ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; TODRALAZINE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER FAILURE; LIVER NECROSIS; LIVER TOXICITY; LYMPHOCYTE TRANSFORMATION TEST; MALE; PRIORITY JOURNAL; RASH;

EID: 0029931879     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510230310     Document Type: Article

References (27)

1. Sherlock S. Disease of the liver and biliary system. London: Blackwell Scientific, 1989:116-128.
2. Takahashi Y, Okuda K. Fulminant hepatitis in Japan: etiology and prognostic prediction. Chinese J Gastroenterol 1993;10:337-350.
3. Clark R, Thompson RPH, Borivakchanyavet V, Widdop B, Davidson AR, Goulding R. Hepatic damage and death from overdosage of paracetamol. Lancet 1973;1:66-70.
4. Hamlyn AN, Douglas AP, James O: The spectrum of paracetamol (acetaminophen) overdose: clinical and epidemiological studies Postgrad Med J 1978;54:400-404.
5. Mitchel DH. Amanita mushroom poisoning. Annu Rev Med 1980;31:51-57.
6. Rodriguez-Iturbe B. Acute yellow-phosphorus poisoning. N Engl J Med 1971;284:157.
7. Mizoguchi Y, Shiba T, Ohnishi F, Monna T, Yamamoto S, Morisawa S. Immunological studies on the drug-induced allergic hepatitis. Gastoroenterologia Japonica 1981;16:249-259.
8. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-679.
9. Machida A, Ohnuma H, Tsuda F, Munekata E, Tanaka T, Akahane Y, Okamoto H, et al. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. HEPATOLOGY 1992;16:886-891.
10. Walton B, Simpson BR, Strnin L, Doniach D, Perrin J, Appleyard AJ. Unexplained hepatitis following halothane. Br Med J 1976;15:1171-1176.
11. Kunelis CT, Peters JL, Edmonson HA. Fatty liver of pregnancy and its relation to tetracycline therapy. Am J Med 1965;38:359-377.
12. Rodman JS, Deutsch DJ, Gutman SI. Methyldopa hepatitis. Am J Med 1976;60:941-948.
13. Toghill PJ, Smith PG, Benton P, Brown RC, Matthews HL. Methyldopa liver damage. Br Med J 1974;31:545-548.
14. Black M, Mitchell JR, Zimmerman HJ, Ishak KG, Epler GR. Isoniazid-associated hepatitis in 114 patients. Gastroenterology 1975;69:289-302.
15. Rosenblum LE, Korn RJ, Zimmerman HJ. Hepatocellular jaundice as a complication of iproniazid therapy. Arch Intern Med 1960;105:583-593.
16. Zimmerman H, Ishak K. Valproate-induced hepatic injury: analysis of 23 fatal cases. HEPATOLOGY 1982;2:591-597.
17. Danan G, Trunet P, Bernuau J, Degott C, Babany G, Pessayre D, Rueff B, et al. Piprofen-induced fulminant hepatitis. Gastroenterology 1985;89:210-213.
18. Stricker BHCh, Spoelstra P. Drug-induced hepatic injury; antihypertensive agents. New York: Elsevier, 1985:95.
19. Perry HM. Late toxity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. Am J Med 1973;54:58-72.
20. Knoblauch K, Cueni B, Schmid SM. Dihydralazin-induzierte, acute hepatitis by IgM-mangel. Schweiz Med Wochenschr 1977;107:651-665.
21. Barnett DB, Hudson SA, Golightly PW. Hydralazine-induced hepatitis. Br Med J 1980;10:1165-1166.
22. Enat R, Rader G, Barzilai D. Leberschaden durch Adelphan. Schweiz Med Wochenschr 1977;107:657-658.
23. Jori GP, Peschle C. Hydralazine disease associated with transient granulomas in the liver. Gastroenterology 1973;64:1167.
24. Bartoli E, Solinas A, Chiandussi L. Acute hepatitis with bridging necrosis due to hydralazine intake. Arch Intern Med 1979;139:698-699.
25. Forster HS. Hepatitis from hydralazine. N Engl J Med 1980;302:1362.
26. Itoh S, Tsukada Y, Itoh Y. Hydralazine-induced hepatitis. Hepatogastroenterology 1981;28:13-16.
27. Itoh S, Yamaha Y, Ichinoe A, Tsukada Y. Hydralazine-induced liver injury. Dig Dis Sci 1980;25:884-887.